Managing nirmatrelvir/ritonavir (Paxlovid) interactions in general practice
Nirmatrelvir/ritonavir (Paxlovid) is indicated in patients who are at high risk of progressing to severe COVID-19. Many of these patients are concomitantly prescribed various medications for other indications. Ritonavir has no activity against SARS-CoV-2, but, administered with nirmatrelvir, acts as...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Continuo
2023-09-01
|
| Series: | Family Medicine & Primary Care Review |
| Subjects: | |
| Online Access: | https://www.termedia.pl/Managing-nirmatrelvir-ritonavir-Paxlovid-interactions-in-general-practice,95,51167,1,1.html |